돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1453356생성일: 2026년 10월 25일

N,N-Dimethylsulfamide → 7H-indolo[2,1-a][2]benzazepine-10-carboxamide

https://huagongshe.com/reaction/1453356

반응식

참여 물질

역할이름HCID투입량
반응물N,N-DimethylsulfamideHCID 134472—
반응물1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
반응물Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 9886157—
반응물1,2,3,4-Tetrahydropyrazino[2,1-a]isoindol-6(10bh)-one hydrochlorideHCID 12901779—
반응물methyl 7H-indolo[2,1-a][2]benzazepine-10-carboxylateHCID 68832135—
촉매4-(Dimethylamino)pyridineHCID 14284—
용매WaterHCID 962—
용매DimethylformamideHCID 6228—
용매TriethylamineHCID 8471—
용매DimethylacetamideHCID 31374—
생성물7H-indolo[2,1-a][2]benzazepine-10-carboxamideHCID 66639690—

반응 단계

To a stirred solution of methyl 7H-indolo[2,1-a][2]benzazepine-10-carboxylate, 13-cyclohexyl, 6-carboxylic acid (200 mg, 0.48 mmol), 1,2,3,4-tetrahydropyrazino[2,1-a]isoindol-6(10bH)-one hydrochloride (130 mg, 0.58 mmol) and triethylamine (0.20 mL) in DMF (3 mL) was added HATU (220 mg, 0.58 mmol). The reaction mixture was stirred at rt for 1 h, diluted with H2O (˜5 mL) stirred for 30 min, and the solids (288 mg) collected by filtration and flushed with H2O. The crude solids were dissolved into MeOH/THF (1:1, 4 mL) and treated with 1M aqueous NaOH (0.75 mL). The reaction mixture was stirred and heated at 80° C. with microwave irradiation for 15 min in a sealed tube. The clear solution was diluted with H2O (5 mL), neutralized with 1M aqueous HCl (0.75 mL) and concentrated to remove organic solvents. The resultant solids (247 mg) were collected by filtration and washed with H2O. To a stirred solution of the crude solids (150 mg, 61% of total collected, ˜0.25 mmol), N,N-dimethylsulfamide (155 mg, 1.25 mmol) and DMAP (150 mg, 1.25 mmol) in dimethylacetamide (2 mL) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (190 mg, 1.0 mmol). The reaction solution was stirred at 50° C. for 2h, diluted with water (5 mL) and the resulting solids were collected by filtration. The mother liquor was concentrated and the solids and the mother liquor were independently purified by preparative HPLC (MeOH/2O with NH4OAc buffer) to yield 7H-indolo[2,1-a][2]benzazepine-10-carboxamide, 13-cyclohexyl-N-[(dimethylamino)sulfonyl]-6-[(3,4,6,10b-tetrahydro-6-oxopyrazino[2,1-a]isoindol-2(1H)-yl)carbonyl] (71 mg total, 27 mg from solids and 44 mg from mother liquor, 0.09 mol, 36% over 3 steps) as a yellow solid. 1H NMR (500 MHz, CDCl3) δ 8.96 (br s, 1H), 8.15 (s, 1H), 7.94 (d, J=8.6 Hz, 1H), 7.83 (s, 1H), 7.62 (d, J=7.6 Hz, 1H), 7.57-7.38 (m, 7H), 6.96 (s, 1H), 5.20 (br s, 1H), 4.44 (br s, 1H), 4.38-3.70 (m, 3H), 3.23-2.66 (m, 5H), 2.98 (s, 6H), 2.11-1.17 (m, 10H). LCMS: m/e 676 (M−H)−, ret time 1.61 min, column A, 2 minute gradient.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07473688B2
출처 데이터셋uspto-grants-2009_01
ORD IDord-0d612cbb58ab4befa3e2bb733ec6f512
출처 메모uspto-grants-2009_01